What is the recommended treatment for neuroschistosomiasis?

Treatment for Neuroschistosomiasis

For neuroschistosomiasis, treat immediately with praziquantel 40 mg/kg twice daily for 5 days combined with high-dose corticosteroids (dexamethasone 4 mg four times daily, reducing after 7 days over 2-6 weeks total), and do NOT delay treatment while awaiting confirmatory serology if clinical suspicion is high based on travel history and compatible neurological findings. 1

Clinical Context and Urgency

Neuroschistosomiasis is a neurological emergency where delayed treatment leads to permanent disability. The median time from presentation to treatment in non-endemic countries averages 33-42 days, which is unacceptably long and results in residual neurological deficits in the majority of patients 2, 3. This delay occurs because clinicians fail to consider the diagnosis or wait for confirmatory testing.

Treatment Algorithm

Step 1: Immediate Corticosteroid Initiation

• Start corticosteroids FIRST, before praziquantel, particularly in acute presentations
• Dexamethasone 4 mg four times daily is the preferred agent 1
• This prevents neurological deterioration from inflammatory response to dying parasites
• In acute Katayama syndrome with neurological symptoms, corticosteroids alone should be given initially to avoid complications 1

Step 2: Antiparasitic Therapy

• Praziquantel 40 mg/kg twice daily for 5 days 1
• Begin after corticosteroids are on board (typically after 1-3 days of steroids)
• All recent case series confirm this dosing regimen 4, 2, 3, 5

Step 3: Corticosteroid Taper

• Continue dexamethasone 4 mg four times daily for 7 days
• Then taper over 2-6 weeks total duration 1
• Longer tapers (up to 6 weeks) may be needed for severe spinal cord involvement

Step 4: Adjunctive Management

• For elevated intracranial pressure: Serial CSF drainage via lumbar puncture plus acetazolamide 4
• For seizures (cerebral involvement): Antiepileptic drugs as clinically indicated
• For hydrocephalus: Ventricular shunting may be required 1

Critical Diagnostic Considerations

Do not wait for confirmatory testing if clinical picture is compatible. Key diagnostic features include:

• Epidemiological risk: Freshwater exposure in endemic areas (sub-Saharan Africa, particularly River Nile, Lake Malawi) 2, 3, 5
• Spinal presentation (most common): Transverse myelitis with back pain, leg weakness, paraesthesia, bladder/bowel dysfunction 1, 2, 3
• Cerebral presentation (less common with S. mansoni/haematobium): Seizures, focal neurological signs, intracranial hypertension 1, 4
• MRI findings: Spinal cord enlargement with enhancement (lower thoracic/conus most common), or cerebral mass lesions 2, 3

Confirmatory testing (but don't delay treatment):

• CSF schistosomal serology (80-100% sensitive) 2, 3
• Blood schistosomal serology
• Stool/urine microscopy (often negative in neuroschistosomiasis) 1, 2
• CSF eosinophilia present in <50% of cases 1

Common Pitfalls to Avoid

1. Waiting for serology results: If travel history and clinical presentation are compatible, start presumptive treatment under tropical medicine guidance 3

2. Starting praziquantel without corticosteroids: This causes acute inflammatory worsening and permanent damage. Always give steroids first 1

3. Inadequate corticosteroid duration: Brief steroid courses (3-5 days only) are insufficient. Plan for 2-6 weeks total 1

4. Missing the diagnosis entirely: Any patient with myelopathy/transverse myelitis and freshwater exposure in endemic areas has neuroschistosomiasis until proven otherwise 2, 3, 5

5. Surgical intervention as first-line: Surgery is reserved only for severe intracranial hypertension unresponsive to medical management or intractable seizures 6. Medical therapy with praziquantel and steroids is first-line treatment

Expected Outcomes

With prompt treatment (within 2 weeks of symptom onset):

• 70% achieve complete symptom resolution 2
• 20-30% have residual deficits (urinary/fecal incontinence, persistent weakness) 2, 3

With delayed treatment (>4 weeks):

• Majority have permanent neurological sequelae 3
• Complete recovery becomes uncommon

The evidence is clear: early recognition and immediate treatment with the praziquantel-corticosteroid combination is the only way to prevent permanent disability from this devastating but treatable condition.